Table 2.
Dialysis day and non-dialysis day outcomes during closed-loop and control periods
| Dialysis days | Non-dialysis days | |||
|---|---|---|---|---|
| Closed-loop (n = 25a) | Control (n = 25a) | Closed-loop (n = 25a) | Control (n = 25a) | |
| Time spent at glucose levels (%) | ||||
| 5.6–10.0 mmol l−1 | 53.9 (14.7) | 37.2 (20.3) | 51.9 (12.5) | 36.3 (22.2) |
| >10.0 mmol l−1 | 41.0 (16.2) | 56.2 (24.9) | 43.5 (14.4) | 58.8 (26.5) |
| <3.9 mmol l−1 | 0.1 (0.0, 0.3) | 0.1 (0.0, 0.9) | 0.0 (0.0, 0.3) | 0.1 (0.0, 1.1) |
| Mean glucose (mmol l−1) | 10.1 (1.5) | 11.5 (2.6) | 10.1 (1.3) | 11.9 (3.2) |
| Standard deviation of glucose (mmol l−1) | 2.8 (0.7) | 3.2 (0.9) | 2.8 (0.6) | 3.0 (0.8) |
| CV of glucose (%) | 27.4 (4.7) | 27.8 (5.6) | 28.0 (3.1) | 26.1 (6.9) |
| Total daily insulin dose (U kg−1) | 0.29 (0.13, 0.51) | 0.36 (0.18, 0.57) | 0.31 (0.16, 0.53) | 0.37 (0.19, 0.59) |
an = 25, as one participant receiving peritoneal dialysis was excluded from this analysis.
Data presented as mean (s.d.) or median (interquartile range).
CV, coefficient of variation.